Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT01627067
Status:
TERMINATED
Last Update Posted:
2020-06-19
First Post:
2012-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exemestane-RAD001-Metformin
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Breast Cancer | View |
| None | Hormone Receptor Positive Metastatic Breast Cancer | View |
| None | Hormone-sensitive | View |
| None | Postmenopausal | View |
| None | Body Mass Index | View |
| None | BMI | View |
| None | Everolimus | View |
| None | Afinitor | View |
| None | RAD001 | View |
| None | Exemestane | View |
| None | Aromasin | View |
| None | Metformin | View |